Denali Therapeutics (DNLI) Debt to Equity (2022)
Historic Debt to Equity for Denali Therapeutics (DNLI) over the last 1 years, with Q4 2022 value amounting to $0.0.
- Denali Therapeutics' Debt to Equity changed N/A to $0.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $0.0, marking a year-over-year change of. This contributed to the annual value of $0.0 for FY2022, which is N/A changed from last year.
- Per Denali Therapeutics' latest filing, its Debt to Equity stood at $0.0 for Q4 2022.
- Denali Therapeutics' 5-year Debt to Equity high stood at $0.0 for Q4 2022, and its period low was $0.0 during Q3 2022.